In the study by Lah et al (1992), lowered cysteine proteinase inhibitor activity in breast carcinoma tissue (i.e., in the low-activity group) was associated with significantly higher increases of cathepsin B and cathepsin L activities than those measured in the high-activity group, indicating higher proteolytic potential in the former group. The gene discussed is CTSB; the disease is breast carcinoma.